Back to results
US 2003/0170244 A1Published application
Inhibition of Fas signaling
OwnerJohn D. Pluenneke, Timothy Connorinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to the general field of treating bone marrow failure and cancer. The invention, in part, utilizes inhibitors of Fas antigen (CD95) induced apoptosis to treat bone marrow failure and to improve cancer therapies.
Claims19
A method for treating bone marrow failure comprising administering to a patient in need thereof an effective amount of an inhibitor of Fas mediated apoptosis.
A method of treating cancer comprising co-administering to a patient in need thereof an effective amount of an inhibitor of Fas mediated apoptosis and an immune cell therapy.
Dependencies are inferred from the claim text.